Skip to main content
Erschienen in: International Urology and Nephrology 10/2016

13.07.2016 | Nephrology - Original Paper

Oxidative stress and hemoglobin–cholesterol adduct in renal patients with different LDL phenotypes

verfasst von: Milica Miljkovic, Jelena Kotur-Stevuljevic, Aleksandra Stefanovic, Aleksandra Zeljkovic, Jelena Vekic, Tamara Gojkovic, Natasa Bogavac-Stanojevic, Milan Nikolic, Sanja Simic-Ogrizovic, Vesna Spasojevic-Kalimanovska, Zorana Jelic-Ivanovic

Erschienen in: International Urology and Nephrology | Ausgabe 10/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Unfavorable lipid profile is a major risk factor for cardiovascular disease in renal pathology. In this study, we compared chronic renal patients and healthy controls with different LDL phenotypes (A or B) in respect of various biochemical parameters related to cardiovascular disease.

Methods

Oxidative stress and anti-oxidative defense parameters [thiobarbituric acid-reacting substances (TBARS), total oxidative status (TOS), total anti-oxidative status (TAS), total protein sulfhydryl (–SH) groups], as well as red blood cell cholesterol distribution were assessed in 40 renal patients and 40 control subjects by standardized assays. LDL particle diameters were determined by polyacrylamide gradient gel electrophoresis. LDL particles are subdivided according to their size into large LDL A phenotype (diameter >25.5 nm) and small LDL B phenotype (diameter ≤25.5 nm).

Results

Renal patients with LDL A phenotype had increased oxidative stress (TOS: p < 0.01, and TBARS: p < 0.001) and decreased total SH– groups (p < 0.001) compared to controls with the same LDL phenotype. A notable decrease in hemoglobin–cholesterol adduct was detected in patients with LDL A phenotype (p < 0.001) and LDL B phenotype (p < 0.05) compared with appropriate controls. LDL B phenotype was characterized with increased TBARS (p < 0.05) compared with LDL A phenotype in control group.

Conclusion

Increased oxidative stress, decreased anti-oxidative defense followed with unfavorable changes in hemoglobin–cholesterol binding capacity, could have important influence on cardiovascular disease risk in renal patients regardless of LDL phenotype.
Literatur
1.
Zurück zum Zitat Sarnak MJ, Levey AS, Schoolwerth AC, Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW (2003) Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation 108:2154–2169CrossRefPubMed Sarnak MJ, Levey AS, Schoolwerth AC, Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW (2003) Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation 108:2154–2169CrossRefPubMed
2.
Zurück zum Zitat Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM (2002) The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 62:1524–1538CrossRefPubMed Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM (2002) The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 62:1524–1538CrossRefPubMed
3.
Zurück zum Zitat Vaziri ND (2006) Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences. Am J Physiol Renal Physiol 290:262–272CrossRef Vaziri ND (2006) Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences. Am J Physiol Renal Physiol 290:262–272CrossRef
4.
Zurück zum Zitat Krauss RM, Burke DJ (1982) Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 23:97–104PubMed Krauss RM, Burke DJ (1982) Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 23:97–104PubMed
5.
Zurück zum Zitat Ohmura H, Mokuno H, Sawano M, Hatsumi C, Mitsugi Y, Watanabe Y, Daida H, Yamaguchi H (2002) Lipid compositional differences of small, dense low-density lipoprotein particle influence its oxidative susceptibility: possible implication of increased risk of coronary artery disease in subjects with phenotype B. Metabolism 51:1081–1087CrossRefPubMed Ohmura H, Mokuno H, Sawano M, Hatsumi C, Mitsugi Y, Watanabe Y, Daida H, Yamaguchi H (2002) Lipid compositional differences of small, dense low-density lipoprotein particle influence its oxidative susceptibility: possible implication of increased risk of coronary artery disease in subjects with phenotype B. Metabolism 51:1081–1087CrossRefPubMed
6.
Zurück zum Zitat Alabakovska S, Todorova B, Labudovic D, Tosheska K (2002) LDL and HDL subclass distribution in patients with end-stage renal diseases. Clin Biochem 35:211–216CrossRefPubMed Alabakovska S, Todorova B, Labudovic D, Tosheska K (2002) LDL and HDL subclass distribution in patients with end-stage renal diseases. Clin Biochem 35:211–216CrossRefPubMed
7.
Zurück zum Zitat Morena M, Delbosc S, Dupuy AM, Canaud B, Cristol JP (2005) Over production of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation. Hemodial Int. 9:37–46CrossRefPubMed Morena M, Delbosc S, Dupuy AM, Canaud B, Cristol JP (2005) Over production of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation. Hemodial Int. 9:37–46CrossRefPubMed
8.
Zurück zum Zitat Vekic J, Kotur-Stevuljevic J, Jelic-Ivanovic Z, Spasic S, Spasojevic-Kalimanovska V, Topic A, Zeljkovic A, Stefanovic A, Zunic G (2007) Association of oxidative stress and PON1 with LDL and HDL particle size in middle-aged subjects. Eur J Clin Invest 37:715–723CrossRefPubMed Vekic J, Kotur-Stevuljevic J, Jelic-Ivanovic Z, Spasic S, Spasojevic-Kalimanovska V, Topic A, Zeljkovic A, Stefanovic A, Zunic G (2007) Association of oxidative stress and PON1 with LDL and HDL particle size in middle-aged subjects. Eur J Clin Invest 37:715–723CrossRefPubMed
9.
Zurück zum Zitat Nikolić M, Stanić D, Antonijević N, Niketić V (2004) Cholesterol bound to hemoglobin in human erythrocytes: A new form of cholesterol in circulation? Clin Biochem 37:22–26CrossRefPubMed Nikolić M, Stanić D, Antonijević N, Niketić V (2004) Cholesterol bound to hemoglobin in human erythrocytes: A new form of cholesterol in circulation? Clin Biochem 37:22–26CrossRefPubMed
10.
Zurück zum Zitat Nikolić M, Stanić D, Baricević I, Jones DR, Nedić O, Niketić V (2007) Efflux of cholesterol and phospholipids derived from the haemoglobin–lipid adduct in human red blood cells into plasma. Clin Biochem 40:305–309CrossRefPubMed Nikolić M, Stanić D, Baricević I, Jones DR, Nedić O, Niketić V (2007) Efflux of cholesterol and phospholipids derived from the haemoglobin–lipid adduct in human red blood cells into plasma. Clin Biochem 40:305–309CrossRefPubMed
11.
Zurück zum Zitat Erel O (2005) A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38:1103–1111CrossRefPubMed Erel O (2005) A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38:1103–1111CrossRefPubMed
12.
Zurück zum Zitat Girotti AW (1998) Lipid hydroperoxide generation, turnover, and effector action in biological systems. J Lipid Res 39:1529–1542PubMed Girotti AW (1998) Lipid hydroperoxide generation, turnover, and effector action in biological systems. J Lipid Res 39:1529–1542PubMed
13.
Zurück zum Zitat Erel O (2004) A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 37:277–2785CrossRefPubMed Erel O (2004) A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 37:277–2785CrossRefPubMed
14.
Zurück zum Zitat Ellman GI (1952) Tissue sulfhydryl groups. Arc Biochem Biophys 82:70–77CrossRef Ellman GI (1952) Tissue sulfhydryl groups. Arc Biochem Biophys 82:70–77CrossRef
15.
Zurück zum Zitat Rainwater DL, Moore PH, Shelledy WR, Dyer TD (1997) Characterization of a composite gradient gel for the electrophoretic separation of lipoproteins. J Lipid Res 38:1261–1266PubMed Rainwater DL, Moore PH, Shelledy WR, Dyer TD (1997) Characterization of a composite gradient gel for the electrophoretic separation of lipoproteins. J Lipid Res 38:1261–1266PubMed
16.
Zurück zum Zitat Vekic J, Topic A, Zeljkovic A, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V (2007) LDL and HDL subclasses and their relationship with Framingham risk score in middle-aged Serbian population. Clin Biochem 40:310–316CrossRefPubMed Vekic J, Topic A, Zeljkovic A, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V (2007) LDL and HDL subclasses and their relationship with Framingham risk score in middle-aged Serbian population. Clin Biochem 40:310–316CrossRefPubMed
17.
Zurück zum Zitat Reed CF, Swisher SN, Marinetti GV, Eden EG (1960) Studies of the lipids of the erythrocyte: I. Quantitative analysis of the lipids of normal human red blood cells. J Lab Clin Med 56:281–289PubMed Reed CF, Swisher SN, Marinetti GV, Eden EG (1960) Studies of the lipids of the erythrocyte: I. Quantitative analysis of the lipids of normal human red blood cells. J Lab Clin Med 56:281–289PubMed
18.
Zurück zum Zitat Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX (2006) Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 17:2034–2047CrossRefPubMed Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX (2006) Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 17:2034–2047CrossRefPubMed
19.
Zurück zum Zitat Siems W, Quast S, Carluccio F, Wiswedel I, Hirsch D, Augustin W, Hampi H, Riehle M, Sommerburg O (2002) Oxidative stress in chronic renal failure as a cardiovascular risk factor. Clin Nephrol 58:S12–S19PubMed Siems W, Quast S, Carluccio F, Wiswedel I, Hirsch D, Augustin W, Hampi H, Riehle M, Sommerburg O (2002) Oxidative stress in chronic renal failure as a cardiovascular risk factor. Clin Nephrol 58:S12–S19PubMed
20.
Zurück zum Zitat Balcerczyk A, Grzelak A, Janaszewska A, Jakubowski W, Koziol S, Marszalek M, Rychlik B, Soszynski M, Bilinski T, Bartosz G (2003) Thiols as major determinants of the total antioxidant capacity. Bio Factors 17:75–82 Balcerczyk A, Grzelak A, Janaszewska A, Jakubowski W, Koziol S, Marszalek M, Rychlik B, Soszynski M, Bilinski T, Bartosz G (2003) Thiols as major determinants of the total antioxidant capacity. Bio Factors 17:75–82
21.
Zurück zum Zitat Prakash M, Shetty JK, Dash S, Barik BK, Sarkar A, Awanti SM, Prabhu R (2008) Urinary protein thiols in different grades of proteinuria. Indian J Clin Biochem 23:404–406CrossRefPubMedPubMedCentral Prakash M, Shetty JK, Dash S, Barik BK, Sarkar A, Awanti SM, Prabhu R (2008) Urinary protein thiols in different grades of proteinuria. Indian J Clin Biochem 23:404–406CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Elshamaa MF, Sabry S, Nabih M, Elghoroury EA, El-Saaid GS, Ismail AAG (2008) Alteration in plasma total antioxidant capacity, cardiotoxic lipid peroxidation product and C-reactive protein: a possible explanation for the increased cardiovascular risk in children on hemodialysis. J Clin Basic Cardiol 11:2–7 Elshamaa MF, Sabry S, Nabih M, Elghoroury EA, El-Saaid GS, Ismail AAG (2008) Alteration in plasma total antioxidant capacity, cardiotoxic lipid peroxidation product and C-reactive protein: a possible explanation for the increased cardiovascular risk in children on hemodialysis. J Clin Basic Cardiol 11:2–7
23.
Zurück zum Zitat Dzięgielewska-Gęsiak S, Wysocka E, Michalak S, Nowakowska-Zajdel E, Kokot T, Muc-Wierzgoń M (2014) Role of lipid peroxidation products, plasma total antioxidant status, and Cu-, Zn-superoxide dismutase activity as biomarkers of oxidative stress in elderly prediabetics. Oxid Med Cell Longev 8:1–8CrossRef Dzięgielewska-Gęsiak S, Wysocka E, Michalak S, Nowakowska-Zajdel E, Kokot T, Muc-Wierzgoń M (2014) Role of lipid peroxidation products, plasma total antioxidant status, and Cu-, Zn-superoxide dismutase activity as biomarkers of oxidative stress in elderly prediabetics. Oxid Med Cell Longev 8:1–8CrossRef
24.
Zurück zum Zitat Hung K, Berisha S, Ritchey B, Santore J, Smith J (2012) Red blood cells play a role in reverse cholesterol transport. Arterioscler Thromb Vasc Biol 32:1460–1465CrossRefPubMedPubMedCentral Hung K, Berisha S, Ritchey B, Santore J, Smith J (2012) Red blood cells play a role in reverse cholesterol transport. Arterioscler Thromb Vasc Biol 32:1460–1465CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Schaefer JA, Parry WL, Mueller CB (1966) Experimental studies of acute renal failure. Histopathology of the renal lesion produced by methemoglobin. J Surg Res 6:247–253CrossRefPubMed Schaefer JA, Parry WL, Mueller CB (1966) Experimental studies of acute renal failure. Histopathology of the renal lesion produced by methemoglobin. J Surg Res 6:247–253CrossRefPubMed
26.
Zurück zum Zitat Harea G, Tsuia A, Crawfordc J, Pateld R (2013) Is methemoglobin an inert bystander, biomarker or a mediator of oxidative stress—the example of anemia? Redox Biology 1:65–69CrossRef Harea G, Tsuia A, Crawfordc J, Pateld R (2013) Is methemoglobin an inert bystander, biomarker or a mediator of oxidative stress—the example of anemia? Redox Biology 1:65–69CrossRef
Metadaten
Titel
Oxidative stress and hemoglobin–cholesterol adduct in renal patients with different LDL phenotypes
verfasst von
Milica Miljkovic
Jelena Kotur-Stevuljevic
Aleksandra Stefanovic
Aleksandra Zeljkovic
Jelena Vekic
Tamara Gojkovic
Natasa Bogavac-Stanojevic
Milan Nikolic
Sanja Simic-Ogrizovic
Vesna Spasojevic-Kalimanovska
Zorana Jelic-Ivanovic
Publikationsdatum
13.07.2016
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 10/2016
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-016-1358-0

Weitere Artikel der Ausgabe 10/2016

International Urology and Nephrology 10/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.